TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Astrazeneca AS
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
492,956
|
453,234
|
414,696 |
Financial expenses |
559
|
413
|
368 |
Earnings before taxes |
23,859
|
18,203
|
11,033 |
Total assets |
340,448
|
335,730
|
315,778 |
Current assets |
339,129
|
334,732
|
314,554 |
Current liabilities |
76,036
|
72,435
|
51,288 |
Equity capital |
263,908
|
263,295
|
262,789 |
- share capital |
76,282
|
81,276
|
85,782 |
Employees (average) | 86 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
77.5%
|
78.4%
|
83.2% |
Turnover per employee | 5,270 | ||
Profit as a percentage of turnover |
4.8%
|
4.0%
|
2.7% |
Return on assets (ROA) |
7.2%
|
5.5%
|
3.6% |
Current ratio |
446.0%
|
462.1%
|
613.3% |
Return on equity (ROE) |
9.0%
|
6.9%
|
4.2% |
Change turnover |
67,572
|
60,320
|
-20,494 |
Change turnover % |
16%
|
15%
|
-5% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.